Related Experiment Video
Updated: Nov 5, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Risk Factors and Anticoagulation Therapy in Patients With Isolated Distal Deep Vein Thrombosis in the Early
Yuping Li1, Junrong Ding1, Lei Shen1
1Department of General Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Insights
Age and postoperative D-dimer levels predict isolated distal deep vein thrombosis (IDDVT) after thoracic surgery. Half-dose anticoagulation is effective and safe for IDDVT treatment, reducing medication needs post-discharge.
Area of Science:
- Vascular Surgery
- Thrombosis Research
- Diagnostic Imaging
Background:
- Isolated distal deep vein thrombosis (IDDVT) comprises about 50% of deep venous thrombosis (DVT) cases.
- Current diagnostic and management strategies for IDDVT are not well-defined and remain controversial.
- Thoracic surgery patients are a key population for DVT risk assessment.
Purpose of the Study:
- To identify risk factors and predictors of IDDVT in patients undergoing thoracic surgery.
- To evaluate the efficacy and safety of different anticoagulation therapy strategies for IDDVT.
- To compare outcomes between full-dose and half-dose anticoagulation regimens.
Main Methods:
- A cohort of 310 patients undergoing thoracic surgery were assessed using whole-leg ultrasonography and D-dimer level measurements.
- Clinical data, including pre- and postoperative D-dimer levels and anticoagulant therapy, were collected.
- Logistic regression analysis was employed to determine independent predictors of postoperative IDDVT.
Main Results:
- Patients with IDDVT showed significantly higher age and postoperative D-dimer levels compared to the non-DVT group.
- Postoperative D-dimer level emerged as a significant independent predictor of IDDVT, even after adjusting for age and surgical method.
- Both full-dose and half-dose anticoagulation regimens demonstrated comparable safety profiles, with no significant adverse effects.
- Half-dose therapy was associated with a significant reduction in the need for post-discharge anticoagulation medication.
Conclusions:
- Elevated age and postoperative D-dimer levels are significant predictors of IDDVT following thoracic surgery.
- Half-dose therapeutic anticoagulation is as effective as full-dose in preventing IDDVT progression.
- Half-dose anticoagulation presents a safe and potentially more cost-effective treatment option for IDDVT patients post-thoracic surgery.
Abstract:
Background: Isolated distal deep vein thrombosis (IDDVT) accounts for ~50% of all patients diagnosed with deep venous thrombosis (DVT), but the diagnosis and optimal management of IDDVT remains unclear and controversial. The aim of this study was to explore potential risk factors and predictors of IDDVT, and to evaluate different strategies of anticoagulation therapy. Methods: A total of 310 consecutive patients after thoracic surgery, who underwent whole-leg ultrasonography as well as routine measurements of D-dimer levels before and after surgery were evaluated. The general clinical data, anticoagulant therapy, pre- and postoperative D-dimer levels were collected. Differences between IDDVT, DVT and non-DVT groups were calculated. Logistic regression analysis was used to analyze risk factors of postoperative IDDVT. Results: Age and postoperative D-dimer levels were significantly higher in IDDVT group than in non DVT group (p = 0.0053 and p < 0.001, respectively). Logistic regression analysis showed that postoperative D-dimer level was a significant independent predictor of IDDVT even when adjusted for age and operation method (p = 0.0003). There were no significant side effects associated with both full-dose and half-dose anticoagulation regimens. Half-dose therapy was associated with a significant decrease in the requirement for anticoagulation medications after discharge (p = 0.0002). Conclusion: Age and D-dimer levels after surgery are strong predictors of IDDVT following thoracic surgery. Half-dose therapeutic anticoagulation has the same efficiency in preventing IDDVT progression, is not associated with any additional risks of adverse effects compared to a full-dose regimen, and may be adopted for treating IDDVT patients after thoracic surgery.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

